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Accurate monitoring of glucose levels constitutes the most important parameter for diabetes management and
treatment planning. In this work, we report on an in vitro glucose monitoring system based on multispectral
photoacoustic sensing (MSPAS) using a cost-effective supercontinuum (SC) laser. We demonstrate for the first
time, to the best of our knowledge, how the use of a broadband SC source allows the identification of distinct
absorption characteristics of two major analytes (glucose and cholesterol) present in the human body in the ex-
tended near-infrared 1540–1840 nm spectral range. Employing the reported SC-based MSPAS system with a
ratiometric analysis, we were able to accurately (coefficient of determination ≥0.938) measure a wide range
of glucose concentration levels in vitro. We further demonstrate clinically accurate prediction of glucose concen-
trations over commonly encountered physiological levels inside the human body (0–400 mg/dL) with reference
to a Clarke error grid analysis. These findings pave the way for devising potentially noninvasive and label-free
continuous glucose monitoring systems. © 2018 Optical Society of America
https://doi.org/10.1364/JOSAB.36.000A61
1. INTRODUCTION
Diabetes mellitus (DM) is a fatal metabolic disease with 424.8
million people affected worldwide, and this number is predicted
to rise to 629 million by 2045 [1]. Improper diagnosis and mon-
itoring of DM can lead to the onset of serious complications
affecting microvascular and macrovascular vessels inside the
human body [2]. To prevent such chronic complications, DM
patients have to monitor their glucose levels frequently. The most
widely used and established approaches for monitoring glucose
levels inside the body rely on amperometric detection and en-
zyme reactions [3–5]. However, these techniques are mostly
invasive (based on finger-pricking). Moreover, compared to
other label-free techniques, the enzyme-based approaches suffer
from reduced sensitivity due to degradation of the enzyme with
time [6]; therefore, several attempts are being made for devising
reliable noninvasive and label-free techniques for the monitoring
of glucose levels inside the human body [7–10].
Photoacoustic (PA)-based sensing is a powerful noninvasive
technique, which has attracted significant attention recently for
determination/analysis of glucose levels [8,11]. The PA-based
sensing techniques were widely employed for glucose detection
in the mid-infrared region due to the presence of fundamental
absorption bands of glucose (9–11 μm) [5,12]. However, the
strong water absorption within this spectral region imposes
significant limitations for noninvasive glucose measurements.
On the other hand, the extended near-infrared (NIR) region
optical window in the biological tissue (1500–1850 nm) is pro-
pitious for devising a noninvasive glucose monitoring tech-
nique due to the higher penetration depths compared to the
techniques based on a shorter wavelength [13]. Figure 1 shows
the measured spectral characteristics of two different analytes
(distilled water and glucose) indicating the well-differentiated
absorption peaks between the two. The spectral difference be-
tween the two analytes can be attributed to the overtone and
combination bands of C─H andO─H bonds [14]. In vitro PA
studies on aqueous glucose within this spectral region have
been performed using commercially available monochromatic
laser sources mainly at 1550 nm [13]. However, because the
absorption spectrum of glucose has identical characteristics
with other analytes inside the human body, such as water and
lipids, these systems are prone to limited sensitivity [15].
MSPAS [16]-based glucose sensing is a promising technique,
which employs a tunable excitation source for establishing the
absorption characteristics of glucose with respect to the other
analytes, thereby enabling the spectral region where glucose has
higher absorption contrast compared to other analytes inside
the human body. Such in vitro MSPAS studies have been re-
cently performed in the NIR and extended NIR region (850–
1900 nm) with tunable optical parametric oscillators (OPOs)
[17–19]. However, while allowing wide wavelength tunability,
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OPOs suffer from high cost and a large footprint, making them
unsuitable candidates for portable MSPAS glucose monitoring
systems.
In this study, we developed, for the first time to our knowl-
edge, a supercontinuum (SC) laser-basedMSPAS system for glu-
cose monitoring in the first overtone band at 1540–1840 nm.
We demonstrate how the proposed system can be used to iden-
tify the absorption characteristics of various analytes and then
select a suitable wavelength region for further investigations.
Based on a simple ratiometric analysis, we demonstrate the fea-
sibility of the system for accurate monitoring of glucose over a
wide range of concentrations. The concentrations used in the
experiments varied from 0–8 g/dL, covering commonly encoun-
tered physiological glucose levels (0–400 mg/dL) inside the hu-
man body. We further employ a linear regression analysis to
predict various glucose concentrations with clinically acceptable
accuracies with respect to a Clarke error grid (CEG) analysis
standard, thereby revealing its true potential toward noninvasive
and label-free continuous glucose monitoring applications.
2. MATERIALS AND METHODS
A. Sample Preparations
The glucose samples were prepared by the process of dissolution,
i.e., different proportions of glucose (D-Glucose, VWR) (1–8 g
in steps of 1 g and 0–400 mg in steps of 50 mg) were measured
using a balance (Entris 224 − 1×, Sartorius) with a precision of
0.2 mg. The weighed samples were subsequently dissolved in
distilled water [pure distilled water (D-Water, VWR) served as
reference]. The glucose solutions were then transferred to the
sample holder and replaced using a syringe after every measure-
ment. The cholesterol used in the experiment was commercial
grade cholesterol (C8667, ≥99%, Sigma-Aldrich). During the
experiments pure cholesterol was filled in a polymer capillary
and placed inside the sample holder.
B. Experimental Setup
The MSPAS system developed for the characterization of the
different analytes and the glucose concentration experiments is
shown in Fig. 2. A home-built high-energy SC laser source
based on a telecom range diode laser-based amplifier and a
few meters of standard single-mode fiber was used as an optical
excitation source. The pulse energy of the SC laser at 30 kHz
pulse repetition rate is 13.3 μJ over a bandwidth of 400 nm
(1500–1900 nm). The detailed configuration of the SC laser
source is described in our previous study [14]. The output from
the SC laser source is collimated using an achromatic lens (L1)
(RC02FC-P01, Thorlabs). The excitation band used for the PA
generation was filtered using a linear variable filter (LVF)
(1.25–2.5 μm, Vortex Optical Coatings), steered using a mirror
(M1) and then focused into the transparent sample holder
(about 5 mm above the surface of the sample holder) using
Fig. 1. Absorption spectra of distilled water (measured in transmission
mode) and D-glucose (measured in diffuse reflection mode) measured
using a commercial FTIR spectrometer (ABB Bomem FTLA2000).
The inset (highlighted area) showing dominant absorption region of
the glucose due to overtone and combination bands of C─H and
O─H bonds in glucose.
Fig. 2. Schematic of the MSPAS system. A home-built high-energy SC laser is used as optical excitation source; the output from the laser is
collimated using a lens (L1), filtered using an LVF, and then focused inside the solution placed on top of a base plate (BP) using an objective
lens (L2). The generated PA signals are detected using a focused transducer, amplified using a low-noise amplifier, sent to an oscilloscope, and saved
to the computer.
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a 5× objective lens (L2). The sample holder is specially designed
to have direct access to the glucose solutions without traversing
any cover slips.
The generated PA signals were detected using a focused
ultrasonic transducer (V320, Panametrics) with a central fre-
quency and 6 dB bandwidth of 7.5 MHz and 5.8 MHz,
respectively. The detection sensitivity of the setup can be maxi-
mized by confocal aligning of both the foci [excitation (spot
size, 19 μm) and detection (spot size, 0.6 mm)]. Therefore,
a high precision stage was used to align the transducer to a con-
focal excitation and detection. The detected signals were then
amplified using two cascaded wide-band low-noise amplifiers
(ZFL-500 LN, Mini-Circuits) and further digitized using a
high-resolution oscilloscope (HDO 9404, Teledyne Lecroy).
The digitized signals from the oscilloscope were then trans-
ferred to a computer for further postprocessing.
C. Methodology and Data Analysis
1. Prediction of Glucose Concentration
The amplitude of the pressure wave generated due to the laser
pulse excitation at the transducer is given by [20,21]
P  KΓαE0, (1)
where K is a constant incorporating the geometrical parameters,
Γ is the Grüeneisen parameter, which depends on the physical
parameters of the sample, α is the absorption coefficient, and
E0 is the excitation pulse energy.
The amplitude of the photoacoustic signal PAsig: detected
by the piezoelectric transducer due to the pressure can be
written as
PAsig:  const:P, (2)
PAsig:  K 0ΓαE0, (3)
where K 0 is a constant that includes the geometrical parameters
as well as the response properties of the piezoelectric transducer.
In the concentration monitoring applications, the change in
the concentration of the sample affects the physical properties
of the sample (Γ) in addition to the optical properties (α) of the
sample, thereby resulting in the stronger PA amplitudes.
Previous studies [8,19,22] have already confirmed that the
variation of the PA signal is linear with the glucose concentra-
tion (for the concentration range used in the experiment).
Therefore, a linear regression was used to predict the PA signal
of unknown glucose concentrations (PAsig:unk:) using known
glucose concentrations.
2. Data Analysis
The acquisition and analysis of the raw data were accomplished
using a MATLAB routine. The routine takes acquired PA sig-
nals from pure distilled water (reference) and the test glucose
solution as two inputs. (To have high accuracy and a signal-to-
noise ratio, 500 PA signals are acquired at every test solution.)
The PA amplitude of the recorded PA signal is the computed
area under the curve of its envelope; therefore, the Hilbert
transformation was used to calculate the envelope of the re-
corded PA signal, and the area under the envelope is extracted.
The PA amplitude at each concentration was then estimated
using the ratiometric analysis of the PA amplitude of the test
glucose solution at respective concentrations and the reference.
The total measurement duration at each concentration was
about 1.6 ms.
3. RESULTS AND DISCUSSION
To assess feasibility of the MSPAS system for the characteriza-
tion of two analytes (glucose and cholesterol), a tunable exci-
tation source (high-energy SC with LVF) was used to first
establish the absorption characteristics of both the analytes.
Figure 3(a) shows the output power spectral density (PSD)
of the SC laser. The inset shows one of the excitation bands at
1620 nm filtered using the LVF.
The PA spectra of both the aqueous glucose solution
(1 g/dL) and the cholesterol were scanned in the wavelength
Fig. 3. (a) Output power spectral density of the SC source. The blue inset shows one of the excitation bands (center wavelength 1620 nm) filtered
using the LVF. (b) The PA spectra of the glucose (1 g/dL) and cholesterol, recorded in the wavelength region 1540 to 1840 nm, with wavelength
steps of 20 nm.
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region from 1540–1840 nm in steps of 20 nm. Figure 3(b)
presents the PA spectra of both analytes. The analytes have dis-
tinct absorption peaks separated by approximately 80 nm in the
wavelength region of interest. The peaks in the PA amplitude
can be attributed to the increased absorption due to the first
overtone and combination region of C─H and O─H bonds
of the analytes. The most pronounced PA amplitude was re-
corded at 1620 nm for the glucose and 1700 nm for the cho-
lesterol. To have high sensitivity and a signal-to-noise ratio, the
1620 nm excitation band was therefore selected for the in vitro
glucose concentration experiments.
To further explore the potential of the current system for
accurate glucose monitoring, the PA amplitudes of different
glucose concentrations varying from 1–8 g/dL in steps of
1 g/dL were recorded. Figure 4(a) presents the variation of the
PA amplitude with respect to the concentration of glucose in
the test solution. It can be clearly observed that the PA ampli-
tude variation shows a close to linear correlation, as the increase
in the concentration of glucose in the test solution increases the
overall absorption, thereby increasing the detected PA ampli-
tude. A linear regression applied to the data set yields a coef-
ficient of determination (R2) of 0.956. The experiments were
repeated for physiological glucose concentrations present inside
the human body (0–400 mg/dL) (i.e., concentrations ranging
from hypoglycemia to hyperglycemia). Figure 4(b) shows the
variation of PA amplitude with respect to the concentration
of the glucose in the test solution. A close to linear correlation
was still valid with a coefficient of determination (R2) of 0.938.
Furthermore, to show the feasibility of the method for clini-
cal applications, CEG analysis was employed. CEG is a widely
used standard to determine the accuracy of glucose monitoring
techniques [23]. CEG divides the correlation plot of glucose
measurements into five different regions—namely, regions A,
B, C, D, and E. It defines a region of sufficient accuracy (within
20% of the reference sensor, zone A) and a region of low but
clinically acceptable accuracy without inappropriate treatment
of the patient (zone B). The results in zones C, D, and E are
potentially dangerous and are therefore clinically significant
errors. The PA signals from 22 different samples with random
glucose concentrations are recorded, and the concentrations
of the glucose inside the samples are predicted (as detailed in
Section 2.C.1). The correlation between the predicted and
the reference glucose concentrations (measured using high-
precision balance) overlaid on the CEG is shown in Fig. 5.
As can be seen in Fig. 5, all the predicted concentrations of
glucose fall in the acceptable accuracy region of the CEG with
a coefficient of determination (R2) of 0.901, thereby showcas-
ing the potential of the measurement technique for further
noninvasive in vivo applications.
4. CONCLUSION
In summary, we have demonstrated the development of an SC
laser-based MSPAS sensing system for in vitro glucose monitor-
ing. The system was used to identify the absorption character-
istics of two major analytes (glucose and cholesterol) over a
wavelength region of 1540–1840 nm. Glucose and cholesterol
Fig. 4. Variation of the PA amplitude as a function of the reference glucose concentration. (a) Higher glucose concentrations levels.
(b) Physiological glucose concentration levels; highlighted areas indicate the regions of hypoglycemia, both normal and hyperglycemia levels.
Fig. 5. Predicted glucose concentrations as a function of the refer-
ence glucose concentrations plotted on CEG.
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show distinct absorption peaks at 1620 nm and 1700 nm, re-
spectively, and the absorption peaks can be attributed to the first
overtone and combination region of C─H and O─H bonds.
We demonstrated how the proposed system can be used to mea-
sure glucose concentration using ratiometric analysis over a broad
range of concentrations, from physiological concentrations com-
monly occurring inside the human body to concentrations as
high as 8 g/dL. Using CEG analysis we further demonstrated
that glucose concentrations can be determined for clinical appli-
cations with sufficient accuracy over the entire range of com-
monly encountered physiological levels inside the human body.
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